• 作者：P. Gutié ; rrez Castrelló ; n^a ; I. Polanco Allué ; ^b ; ^{ipolanco.hulp@salud.madrid.org} ; E. Salazar Lindo^c
• 关键词：Gastroenteritis aguda ; Menores 5 añ ; os ; Aná ; lisis de la evidencia ; Rehidrataci&oacute ; n oral ; F&oacute ; rmulas infantiles ; Alimentaci&oacute ; n ; Racecadotrilo ; Zinc ; Antiemé ; ticos ; Acetorfan ; Loperamida ; Probi&oacute ; ticos ; Esmectita
• 刊名：Anales de Pediatr铆a
• 出版年：2010
• 期刊代码：pca47_16954033
• 类别：med
• 出版时间：March 2010
• 卷：72
• 期：3
• 页码：220.e1-220.e20
• 文件大小：672 K

Acute gastroenteritis (AG) morbidity and mortality rates in infants and prescholars continue to be high in developing countries. Authors want to develop an evidence-based document that supports decision making regarding AG therapy in infants and children younger than 5 y/o. A systematic review of the literature was performed (May, 2008). Evidence grading was established according to Oxford guidelines and Latin American experts submitted their opinions on the recommendations generated.

Oral rehydration solutions are the threatment's keystone for children with AG, showing lesser complications due to therapy than IV fluids. AG is no contraindication of a normal diet. Racecadotril, zinc and smectite can contribute to AG treatment, as well as Lactobacillus GG and Saccharomycces boulardii. No other drugs are recommended. It is recommended to treat children presenting AG with oral rehydration solutions among racecadotril, zinc or smectite as well as some probiotics.